Skip to main content

Table 3 Unique patient counts and calculated disease percentages by HCS, and estimates from the medical literature

From: The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems

Total patient count

NCATS

Eversana

Sanford

OHSU

Med lit

4,333,968

*

1,625,685

1,039,213

N/A

Disease

Unique patient count

Percentage (%)

Unique patient count

Percentage (%)

Unique patient count

Percentage (%)

Unique patient count

Percentage (%)

Estimated prevalence

SCD

10,416

0.2400

38,388

0.0340

55

0.0034%

259

0.0250

0.0308% [38]

MD

2763

0.0640

34,956

0.0313

407

0.0250

709

0.0680

0.0769% [38]

CF

2581

0.0600

13,856

0.0120

246

0.0151

567

0.0550

0.0090% [38]

UCD

1487

0.0340

9423

0.0084

58

0.0036

93

0.0090

0.0029% [39]

HHT

1119

0.0260

21,259

0.0190

28

0.0017

341

0.0330

0.0200% [38]

BD

941

0.0220

7,821

0.0070

3

0.0002

145

0.0140

0.0030% [38]

LGS

917

0.0210

42,837

0.0380

229

0.0141

503

0.0480

0.0001% [38]

FSGS

859

0.0200

11,192

0.0100

128

0.0079

153

0.0150

0.0007% [38]

EOE

755

0.0170

55,055

0.0500

581

0.0357

354

0.0340

0.0500% [38]

OI

573

0.0130

5397

0.0050

73

0.0045

122

0.0120

0.0050% [38]

MNGIE

467

0.0110

7144

0.0060

5

0.0003

66

0.0060

0.0010% [41]

Pheo

250

0.0060

15,521

0.0138

19

0.0012

100

0.0100

0.0005% [40]

TA

117

0.0030

1241

0.0011

14

0.0009

24

0.0020

0.0002% [38]

  1. Unique patient counts by disease extracted from each healthcare system database, and estimated disease percentages within each HCS and for the US population using medical literature/published data sources. Unique patient counts which were used to calculate per patient cost and the total disease cost by disease in Figs. 3, 4
  2. SCD sickle cell disease, MD muscular dystrophy, CF cystic fibrosis, HHT hereditary hemorrhagic telangiectasia, BD Batten disease, LGS Lennox Gastaut syndrome, FSGS focal segmental glomerulosclerosis, EOE eosinophilic esophagitis, OI osteogenesis imperfecta, MNGIE mitochondrial neurogastrointestinal encephalopathy, Pheo pheochromocytoma, TA Takayasu’s arteritis, CMT Charcot Marie Tooth disease, NCATS National Center for Advancing Translational Sciences, OHSU Oregon Health and Science University, Med Lit medical literature/public data sources, N/A not applicable
  3. *Drawn from ~ 195 million patients in the healthcare system database. Total patient count varied by disease, see Table 1